Solo Eye Drop Treatment in Development for Keratoconus

At our last AGM, Professor Roger Buckley told us about an exciting new development which could lead to non-invasive eye drops being used to stop the progression of keratoconus – a pharmacological version of CXL.

A description of his talk may be found in our Summer 2018 Newsletter.

You can read more about this research in this scientific journal.